Table 1.
Mean age of study participants and age-standardized* population estimates (95% CIs) for important characteristics of the study population
| Men (n=687) |
Women (n=761) |
|
|---|---|---|
| Age, years | 52.7 (51.4–53.9) | 52.1 (51.0–53.3) |
| Current Smoking (%) † | 30.1 (26.1–34.1) | 13.6 (10.7–16.5) |
| Current alcohol consumption (%)† | 56.6 (52.3–60.9) | 22.1 (18.4–25.8) |
| Body Height, cm † | 169.8 (169.1–170.4) | 156.6 (156.1–157.1) |
| Body Weight, Kg † | 76.2 (75.0–77.3) | 63.0 (62.0–63.9) |
| Body Mass Index, kg/m2 † | 26.4 (26.0–26.7) | 25.7 (25.4–26.1) |
| Waist Circumference, cm † | 93.0 (92.2–93.8) | 84.9 (84.0–85.7) |
| Use of hormonal contraceptives (%) | --- | 7.2 (4.8–9.5) |
| Use of hormone-replacement therapy (%) | --- | 2.8 (1.8–3.8) |
| Systolic Blood Pressure, mmHg † | 115.6 (114.6–116.7) | 113.4 (112.3–114.4) |
| Diastolic Blood Pressure, mmHg † | 77.5 (76.8–78.2) | 74.9 (74.2–75.6) |
| Total Cholesterol, mg/dL | 194.6 (191.4–197.9) | 197.2 (194.4–200.1) |
| HDL-Cholesterol, mg/dL † | 45.5 (44.7–46.2) | 48.7 (48.0–49.5) |
| Low HDL-Cholesterol (%)‡ | 28.7 (24.7–32.6) | 56.5 (52.4–60.6) |
| LDL-Cholesterol, mg/dL | 115.2 (112.5–117.9) | 117.2 (115.0–119.3) |
| Triglycerides, mg/dL † | 185.6 (177.9–193.3) | 141.9 (136.8–146.9) |
| C-reactive protein, mg/dL ** | 129.0 (116.7–142.6) | 127.7 (115.6–142.6) |
| Impaired fasting glucose (%) † ‡ | 4.1 (2.4–5.7) | 2.4 (1.6–3.3) |
| Diabetes mellitus (%)‡ | 4.5 (3.0–5.9) | 4.1 (2.7–5.5) |
| Antihypertensive medication use (%) | 8.4 (6.6–10.2) | 11.2 (9.6–12.7) |
| Cholesterol-lowering medication use (%) | 4.5 (2.8–6.3) | 1.8 (1.1–2.5) |
| Hypertension (%) | 18.0 (15.1–21.0) | 17.9 (15.9–18.8) |
| Hypercholesterolemia (%) | 15.9 (12.8–19.0) | 15.2 (12.9–17.6) |
*
According to World Health Organization estimates on standard world population between 2000–2025
†
P<0.001 for difference between men and women.
‡
Low HDL-cholesterol was defined as <40 mg/dL in men and <50 mg/dL in women; impaired fasting glucose was defined as fasting blood glucose=100–125 mg/dL; diabetes mellitus was defined as fasting blood glucose ≥126mg/dL or antidiabetic pharmacologic treatment.
**
geometric mean
HDL= High-density lipoprotein; LDL=Low-density lipoprotein;